Samuel Jenness, PhD

Skip to main content
Samuel Jenness

Associate Professor

Department of Epidemiology

Rollins School of Public Health

Emory University

I am an infectious disease epidemiologist specializing in mathematical and computational approaches for infectious disease dynamics through the framework of network science.

As an Associate Professor in the Department of Epidemiology at the Rollins School of Public Health of Emory University, I lead the EpiModel Research Lab and also collaborate on many projects in both methods and applications for infectious disease epidemiology. I teach courses in infectious disease epidemiology and modeling methods, and I am the faculty director of our Infectious Disease Epidemiology Certificate program.

  Research Interests

My methodological research focuses on the development of an open-source software platform for epidemic modeling, EpiModel, which allows users to build, simulate, and analyze complex mechanistic models for infectious disease systems. EpiModel provides a powerful toolkit for modeling dynamic contact networks that are fundamental for representing transmission of diseases requiring direct contact. EpiModel has been used in over 130 scientific publications by our group and infectious disease modeling researchers around the world.

My applied research focuses on the epidemiology of sexually transmitted and respiratory infectious diseases. I am interested in how we can use mechanistic modeling and network science frameworks to understand the drivers of these diseases, and to design and evaluate effective prevention strategies. Recent applications have used models to investigate the co-circulation of multiple pathogens within the same population where the risk for acquiring one disease depends on the epidemic dynamics of other infections transmitted along the same contact network.

More broadly, the work of my EpiModel Research Lab involves addressing these questions with research in the following domains:

  • Infectious disease epidemiology
  • Mechanistic and mathematical modeling of infectious disease
  • Network science
  • Survey research design and analysis
  • Computational epidemiology and scientific software development

I actively support and mentor PhD students, postdocs, and research staff who work with me in the EpiModel Research Lab.

  Featured Publications

  • Main results figure from Potential Risks and Benefits of Low-Barrier Access and Monitoring for HIV Preexposure Prophylaxis: A Modeling Study

    Potential Risks and Benefits of Low-Barrier Access and Monitoring for HIV Preexposure Prophylaxis: A Modeling Study

    Le Guillou A, Marcus JL, Krakower DS, et al

    Journal of Infectious Diseases · 2026

    A 50% increase in PrEP coverage through over-the-counter delivery averted 15.4% of HIV infections, and confirming HIV-negative status at initiation cut TDF/FTC resistance by more than 90% without reducing that benefit.

  • Main results figure from Role of Casual Contact in Drug-Resistant Tuberculosis Transmission: A Molecular Epidemiology Study

    Role of Casual Contact in Drug-Resistant Tuberculosis Transmission: A Molecular Epidemiology Study

    Gandhi NR, Naidoo K, Lutchminarain K, et al

    American Journal of Respiratory and Critical Care Medicine · 2026

    Among genotypically clustered cases of drug-resistant tuberculosis, 49% were linked through casual contact in community locations, compared with 9% through close contact.

  • Main results figure from Characterizing Social Behavior Relevant for Infectious Disease Transmission in Four Low- and Middle-Income Countries, 2021–2023

    Characterizing Social Behavior Relevant for Infectious Disease Transmission in Four Low- and Middle-Income Countries, 2021–2023

    Nelson KN, Kiti MC, Shiiba M, et al

    Nature Communications · 2025

    Two-day contact diaries from 5,085 participants across four low- and middle-income countries yielded 84,829 contacts, with age patterns that diverged from projections extrapolated from high-income settings.

  • Main results figure from Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis

    Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis

    Traeger MW, Leyden WA, Volk JE, et al

    JAMA Internal Medicine · 2025

    After doxy-PEP initiation, quarterly chlamydia positivity fell from 9.6% to 2.0% and syphilis from 1.7% to 0.3%, while gonorrhea moved from 10.2% to 9.0%.

All publications →